COMMUNIQUÉS West-GlobeNewswire

Saniona progress to second part of Phase 2a study for Tesomet in Prader-Willi Syndrome based on positive results in adult patients
26/04/2018
PRESS RELEASE April 26, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has obtained approval to initiate the second part of its Phase 2a trial for Tesomet in adolescents [...]
Bone Therapeutics SA : Strengthens Board with the Appointment of Claudia D'Augusta as Non-Executive Director
26/04/2018
Press release Bone Therapeutics Strengthens Board with the Appointment of Claudia D'Augusta as Non-Executive Director Claudia D'Augusta brings significant financial and capital markets experience Gosselies, Belgium, 26 [...]
Bone Therapeutics SA étoffe son Conseil d'administration avec la nomination de Claudia D'Augusta en tant qu'Administrateur non-exécutif
26/04/2018
Communiqué de presse Bone Therapeutics étoffe son Conseil d'administration avec la nomination de Claudia D'Augusta en tant qu'Administrateur non-exécutif Claudia D'Augusta apporte une expérience significative des [...]
Vistin Pharma ASA : Delivers 22% revenue growth in first quarter 2018
26/04/2018
Oslo, Norway, 26 April 2018 Vistin Pharma ASA delivers a revenue growth of 22 percent from NOK 43.4 million in the first quarter 2017 to NOK 52.8 million in the first quarter 2018. The underlying demand for metformin is [...]
MDxHealth Announces Positive Clinical Updates for ConfirmMDx
26/04/2018
NEWS RELEASE REGULATED INFORMATION MDxHealth Announces Positive Clinical Updates for ConfirmMDx ConfirmMDx included in the 2018 EAU Guidelines for Prostate Cancer Publication of ConfirmMDx Validation Study in African [...]
MDxHealth annonce des mises à jour cliniques positives pour ConfirmMDx
26/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS REGLEMENTÉES MDxHealth annonce des mises à jour cliniques positives pour ConfirmMDx ConfirmMDx inclus dans les directives 2018 émises par l'EAU pour le cancer de la prostate Publication [...]
Biocartis Group NV: BIOCARTIS Q1 2018 BUSINESS UPDATE
26/04/2018
PRESS RELEASE: REGULATED INFORMATION Thursday, 26 April 2018, 07:00 CEST BIOCARTIS Q1 2018 BUSINESS UPDATE Mechelen, Belgium , 26 April 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
26/04/2018
Company announcement - No. 12/2018 Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome Glepaglutide is in development as a new treatment option for patients with short [...]
Medibio Announces Scientific Advisory Board
26/04/2018
Led by Board of Director Franklyn Prendergast, M.D., Ph.D. and Chief Medical Officer Archie Defillo, M.D. Key external members include Martin Chapman, M.D.; Joel Ehrenkranz, M.D.; Mark A. Frye, M.D.; Lawrence Hunter, Ph [...]
Western Canadian Cannabis Use: Proprietary Study Indicates Half of Western Canadians Are Cannabis Users, Lapsed Users, or Interested in Trying Cannabis
26/04/2018
EDMONTON, Alberta, April 25, 2018 (GLOBE NEWSWIRE) -- Modern Leaf, an industry leading cannabis education and e-commerce platform, recently commissioned a research study of 2,005 Western Canadians from Manitoba, [...]
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
26/04/2018
WALTHAM, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX ) today announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price [...]
Nextech to Showcase Enhanced Cloud-Based Technology at The Aesthetic Meeting 2018
25/04/2018
Full suite of Electronic Medical Record and Practice Management solutions now include new reporting and mobility functionalities for plastic surgeons TAMPA, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a [...]
Dentsply Sirona Declares Quarterly Cash Dividend
25/04/2018
YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]
Paratek Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
25/04/2018
BOSTON, April 25, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
25/04/2018
Pivotal Phase 2 AZEDRA Data Selected for Oral Presentation NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging [...]
R1 RCM to Release First Quarter 2018 Results on May 9
25/04/2018
CHICAGO, April 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]
Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7th
25/04/2018
YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live [...]
Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting
25/04/2018
COLUMBIA, Md., April 25, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine [...]
BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting
25/04/2018
NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that the [...]

Pages